The IgG and IgM isotypes of anti-annexin A5 antibodies: relevance for primary antiphospholipid syndrome

Journal of Thrombosis and Thrombolysis

Volumn 42, Issue 4, 2016, Pages 552-557

  Bećarević, Mirjana ^a  

^a UNIVERSITY OF NOVI SAD   (Serbia)

Author keywords

Annexin A5; Anti annexin A5 antibodies; IgG and IgM isotype; Primary antiphospholipid syndrome

Indexed keywords

ANNEXIN A5 ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIPOCORTIN 5; PROTEIN ANTIBODY; UNCLASSIFIED DRUG; AUTOANTIBODY;

ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; CLINICAL FEATURE; HUMAN; NONHUMAN; PREGNANCY DISORDER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN STRUCTURE; RECURRENT PREGNANCY LOSS; REVIEW; SEROLOGY; VEIN THROMBOSIS; ANIMAL; BLOOD; FEMALE; IMMUNOLOGY; MALE; PREGNANCY; PREGNANCY COMPLICATION;

ANIMALS; ANNEXIN A5; ANTIPHOSPHOLIPID SYNDROME; AUTOANTIBODIES; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 84974781463     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-016-1389-5     Document Type: Review

References (45)

1. van den Hoogen LL, van Roon JAG, Radstake TRDJ, Fritsch-Stork RDE, Derksen RHWM (2015) Delineating the deranged immune system in the antiphospholipid syndrome. Autoimmun Rev. doi:10.1016/j.autrev.2015.08.011
2. Bertolaccini ML, Amengual O, Andreoli L, Atsumi T, Chighizola CB, Forastiero R et al (2014) 14th International congress on antiphospholipid antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends. Autoimmun Rev 13:917–930
3. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome. J Thromb Haemost 4:295–306
4. Lee KO, Kim WJ, Na SJ, Heo JH, Lee KY (2011) Clinical significance of anti-annexin V antibody in acute cerebral ischemia. J Neurol Sci 305:53–56
5. Bećarević M, Lj Stojanovich, Ignjatović S, Dopsaj V (2016) The IgM isotype of anti-annexin a5 antibodies and multiple positivity of conventional antiphospholipid antibodies: increasing the number of clinical manifestations of primary antiphospholipid syndrome. Clin Rheumatol 35:1361–1365
6. http://www24.brinkster.com/annexins/
7. Gerke V, Moss SE (2002) Annexins: from structure to function. Physiol Rev 82:331–371
8. Peng B, Guo C, Guan H, Liu S, Sun MZ (2014) Annexin A5 as a potential marker in tumors. Clin Chim Acta 427:42–48
9. Laohavisit A, Davies JM (2009) Multifunctional annexins. Plant Sci 177:532–539
10. Hayes MJ, Longbottom RE, Moss SE (2007) Annexinopathies. In: Carafoli E, Brini M (eds) Calcium signaling and disease. Springer, New York, pp 1–28
11. Rescher U, Gerke V (2004) Annexins—unique membrane binding proteins with diverse functions. J Cell Sci 117:2631–2639
12. Bouter A, Carmeille R, Gounou C, Bouvet F, Degrelle SA, Evain-Brion D et al (2015) Annexin A5 and cell membrane repair. Placenta. doi:10.1016/j.placenta.2015.01.193
13. Trouvé P, Le Drévo MA, Kerbiriou M, Friocourt G, Fichou Y, Gillet D et al (2007) Annexin V is directly involved in cystic fibrosis transmembrane conductance regulator’s chloride channel function. Biochim Biophys Acta 1772:1121–1133
14. van Tits LJH, van Heerde WL, van der Vleuten GM, de Graaf J, Grobbee DE, van de Vijver LPL et al (2007) Plasma annexin A5 level relates inversely to the severity of coronary stenosis. Biochem Biophys Res Comm 356:674–680
15. Rand JH, Wu XX, Quinn AS, Taatjes DJ (2010) The annexin A5-mediated pathogenic mechanism in the antiphospholipid syndrome: role in pregnancy losses and thrombosis. Lupus 19:460–469
16. Iaccarino L, Ghirardello A, Canova M, Zen M, Bettio S, Nalotto L et al (2011) Anti-annexins autoantibodies: their role as biomarkers of autoimmune diseases. Autoimmun Rev 10:553–558
17. Cederholm A, Svenungsson E, Jensen-Urstad K, Trollmo C, Ulfgren AK, Swedenborg J, Fei GZ, Frostegard J (2005) Decreased binding of annexin V to endothelial cells: a potential mechanism in atherothrombosis of patients with systemic lupus erythematosus. Arterioscler Thromb Vasc Biol 25:198–203
18. Cederholm A, Johan Frostegard J (2005) Annexin A5 in cardiovascular disease and systemic lupus erythematosus. Immunobiology 210:761–768
19. Cederholm A, Frostegård J (2007) Annexin A5 as a novel player in prevention of atherothrombosis in SLE and in the general population. Ann NY Acad Sci 1108:96–103
20. Bećarević M, Singh S, Majkić-Singh N (2008) Oxidized LDL, anti-oxidized LDL and anti-annexin A5 antibodies in primary antiphospholipid syndrome. Clin Lab 54:97–101
21. Domeij H, Hua X, Su J, Bäcklund A, Yan Z, Frostegård AG et al (2013) Annexin A5 inhibits atherogenic and pro-inflammatory effects oflysophosphatidylcholine. Prostag Other Lipid Mediat 106:72–78
22. 2+ handling in the heart. Cardiovasc Res 65:793–802
23. Markoff A, Gerke V (2005) Expression and functions of annexins in the kidney. Am J Physiol Ren Physiol 289:949–956
24. van Heerde L, Lap P, Schoormans S, de Groot PG, Reutelingsperger C, Vroom T (2004) Localization of annexin A5 in human tissues. Annexins 1:e56–e62
25. Shu F, Sugimura M, Kanayama N, Kobayashi H, Kobayashi T, Terao T (2000) Immunohistochemical study of annexin V expression in placentae of preeclamsia. Gynecol Obstet Investig 49:17–23
26. Ulander VM, Stefanovic V, Masuda J, Suzuki K, Hiilesmaa V, Kaaja R (2007) Plasma levels of annexins IV and V in relation to antiphospholipid antibody status in women with a history of recurrent miscarriage. Thromb Res 120:865–870
27. Esposito G, Tamby MC, Chanseaud Y, Servettaz A, Guillevin L, Mouthon L (2005) Anti-annexin V antibodies: are they prothrombotic? Autoimmun Rev 4:55–60
28. Gris JC, Quéré I, Sanmarco M, Boutiere B, Mercier E, Amiral J, Hubert AM et al (2008) Antiphospholipid and antiprotein syndromes in non-thrombotic, non-autoimmune women with unexplained recurrent primary early foetal loss The nîmes obstetricians and haematologists study-NOHA. Thromb Haemost 84:228–236
29. Zammiti W, Mtiraoui N, Hidar S, FekihM AlmawiWY, Mahjoub T (2006) Antibodies to β2- glycoprotein I and annexin V in women with early and late idiopathic recurrent spontaneous abortions. Arch Gynecol Obstet 274:261–265
30. Rezk A, Abdel-Hafeez N, Rageh IM, Abdalla W (2010) Anti-annexin as a marker in patients with recurrent miscarriages. Middle East Fertil Soc J 15:47–50
31. Irman S, Skarabot M, Musevc I, Rozman B, Bozic B (2011) The use of atomic force microscopy to study the pathologic effects of anti-annexin autoantibodies. J Autoimmun 36:98–105
32. Bizzaro N, Tonutti E, Villalta D, Tampoia M, Tozzoli R (2005) Prevalence and clinical correlation of anti-phospholipid-binding protein antibodies in anticardiolipin negative patients with systemic lupus erythematosus and women with unexplained recurrent miscarriages. Arch Pathol Lab Med 129:61–68
33. Nojima J, Kuratsune H, Suehisa E, Futsukaichi Y, Yamanishi H, Machii T et al (2001) Association between the prevalence of antibodies to beta(2)-glycoprotein I, prothrombin, protein C, protein S, and annexin V in patients with systemic lupus erythematosus and thrombotic and thrombocytopenic complications. Clin Chem 47:1008–1015
34. Arnold J, Holmes Z, Pickering W, Farmer C, Regan L, Cohen H (2001) Anti-beta2glicoprotein I and of anti-annexin V antibodies in women with recurrent miscarriages. Br J Haematol 113:911–914
35. De Laat B, Derksen RHWM, Mackie IJ et al (2006) Annexin A5 polimorphism (−1C > T) and the presence of anti-annexin A5 antibodies in the antiphospholipid syndrome. Ann Rheum Dis 65(11):1468–1472
36. Roldán V, Marín F, Pineda J, Marco P, Corral J, Climent V et al (2002) Annexin V levels in survivors of early myocardial infarction. Rev Esp Cardiol 55:1230–1234
37. Nayfe R, Uthman I, Aoun J, Aldin ES, Merashil M, Khamashta MA (2013) Seronegative antiphospholipid syndrome. Rheumatology 52:1358–1367
38. Gaspersic N, Rot U, Cucnik S, Bozic B, Kveder T, Rozman B (2003) Low prevalence of antiphospholipid antibodies in a series of young patients with cerebrovascular disease. Clin Exp Rheumatol 21:680
39. Bećarević M, Ignjatović S, Majkić-Singh N (2012) Deterioration of thromboses in primary antiphospholipid syndrome: TNF-alpha and anti-annexin A5 antibodies. Clin Lab 58:1079–1084
40. Rand JH, Wu XX (2004) Antibody-mediated interference with annexins in the antiphospholipid syndrome. Thromb Res 114:383–389
41. Del Ross T, Ruffatti A, Cuffaro S, Tonello M, Calliagaro A, Favaro M et al (2015) The clinical relevance of the IgM isotype of antiphospholipid antibodies in the vascular antiphospholipid syndrome. Thromb Res. doi:10.1016/j.thromres.2015.08.019
42. Galli M, Luciani D, Bertolini G, Barbui T (2003) Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood 101(5):1827–1832
43. Forastiero R, Martinuzzo M, Pombo G, Puente D, Rossi A, Celebrin L et al (2005) A prospective study of antibodies to beta2-glycoprotein I and prothrombin, and a risk of thrombosis. J Thromb Haemost 3(6):1231–1238
44. Forastiero R (2014) Multiple antiphospholipid antibodies positivity and antiphospholipid syndrome criteria re-evaluation. Lupus 23(12):1252–1254
45. Pengo V (2011) Antiphospholipid syndrome: interpretation of laboratory data. J Thromb Haemost 9(2):402–403